Monitoring particulate contamination in biopharmaceuticals with FlowCam
2 Oct 2022
Measuring and monitoring particulate matter in injectable therapeutics is essential for biopharmaceutical formulation development, manufacturing, and packaging and is required by regulatory bodies such as the FDA. In this video, learn about the FlowCam range of imaging particle analyzers from Yokogawa Fluid Imaging Technologies. These instruments combine digital imaging, flow cytometry, and microscopy into a single instrument and are designed for superior particle analysis.
Related Products
Request Quote for All Products
FlowCam 8000
Yokogawa Fluid Imaging Technologies, IncThrough its exceptional image quality and the widest size range available, FlowCam® 8000 represents state-of-the-art particle imaging technology. Analyze thousands of particles in less than a minute and comprehensively characterize the size, count, morphology, and identity of subvisible and visible particulates in their native solvent.
FlowCam LO
Yokogawa Fluid Imaging Technologies, IncInnovative particle characterization with FlowCam® LO combines flow imaging microscopy (FIM) and light obscuration (LO) into a single analytical solution. Beyond the compendial light obscuration method to fulfill USP <787> and <788> requirements, flow imaging microscopy provides an orthogonal method for quality control of subvisible particulate matter.
FlowCam Nano
Yokogawa Fluid Imaging Technologies, IncFlowCam® Nano provides dynamic image analysis of submicron particles from 300 nm to 2 µm, bridging the gap between traditional flow imaging microscopy and other particle analysis techniques. Use FlowCam Nano for early detection of aggregates and contaminant monitoring for protein formulations, nano-drug delivery systems, characterization of bacteria, bioprocess monitoring, and materials characterization.
